Erjin Wang
Xingxuan He2
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Department of Health Toxicology, Xiangya School of Public Health, Central South University, Changsha, China
- 2Department of Human Genetics and Genomic Sciences, Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, United States
A Corrigendum on
The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis
By: Wang E, He X and Zeng M (2019) Front. Pharmacol. 9:1504. doi: 10.3389/fphar.2018.01504
In the original article, the reference for “Borel et al., 2010” was incorrectly written as “Borel, J. F., Feurer, C., Hiestand, P. C., and Stähelin, H. (2010). Transforming growth factor-beta1 induces transdifferentiation of myoblasts into myofibroblasts via up-regulation of sphingosine kinase-1/S1P3 axis. Mol. Biol. Cell 21, 1111–1124. doi: 10.1091/mbc.E09-09-0812.” It should be “Cencetti, F., Bernacchioni, C., Nincheri, P., Donati, C., and Bruni, P. (2010). Transforming growth factor-beta1 induces transdifferentiation of myoblasts into myofibroblasts via up-regulation of sphingosine kinase-1/S1P3 axis. Mol. Biol. Cell 21, 1111–1124. doi: 10.1091/mbc.E09-09-0812.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: sphingosine 1-phosphate, tissue fibrosis, SphK, S1PRs, clinical treatment
Citation: Wang E, He X and Zeng M (2020) Corrigendum: The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis. Front. Pharmacol. 11:594471. doi: 10.3389/fphar.2020.594471
Received: 13 August 2020; Accepted: 14 August 2020;
Published: 30 October 2020.
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
Copyright © 2020 Wang, He and Zeng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ming Zeng, emVuZ21pbmdAY3N1LmVkdS5jbg==